The leukemia mortality rate in Japan is projected to experience a year-over-year increase throughout the 2024-2028 period. In 2023, the mortality figure stood slightly lower than in subsequent forecasted years. The mortality rate is expected to grow from 9.34 thousand deaths in 2024 to 9.69 thousand deaths by 2028. The compounded annual growth rate (CAGR) over these five years indicates a gradual upward trend, reflecting persistent challenges in reducing leukemia-related fatalities in Japan.
Future trends to watch for include advancements in medical treatment and early detection technologies, which could impact mortality rates. Additionally, health policy changes and public health initiatives aimed at cancer prevention and care improvements will be crucial in shaping future leukemia mortality trends.
